ARCHITECT BNP ASSAY, MODEL 8K28

Test, Natriuretic Peptide

FUJIREBIO DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Fujirebio Diagnostics, Inc. with the FDA for Architect Bnp Assay, Model 8k28.

Pre-market Notification Details

Device IDK060964
510k NumberK060964
Device Name:ARCHITECT BNP ASSAY, MODEL 8K28
ClassificationTest, Natriuretic Peptide
Applicant FUJIREBIO DIAGNOSTICS, INC. 201 GREAT VALLEY PKWY. Malvern,  PA  19355
ContactDiana L Wolaniuk
CorrespondentDiana L Wolaniuk
FUJIREBIO DIAGNOSTICS, INC. 201 GREAT VALLEY PKWY. Malvern,  PA  19355
Product CodeNBC  
Subsequent Product CodeJIT
Subsequent Product CodeJJX
CFR Regulation Number862.1117 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-04-07
Decision Date2006-05-25
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00380740145286 K060964 000
00380740190378 K060964 000
00380740017460 K060964 000
00380740017477 K060964 000
00380740017484 K060964 000
00380740017491 K060964 000
00380740145255 K060964 000
00380740145262 K060964 000
00380740145279 K060964 000
00380740190361 K060964 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.